INS CD-STUTTERING COVERAGE
HB2628 requires health insurance coverage for speech therapy used to treat stuttering. Beginning with policies and managed care plans amended, delivered, issued, or renewed on or after January 1, 2027, group and individual accident and health policies that already cover habilitative services, rehabilitative services, or both must cover habilitative speech therapy and/or rehabilitative speech therapy for stuttering. The bill specifies that coverage applies regardless of whether the stuttering is classified as developmental and sets out definitions for habilitative and rehabilitative services.
The bill also extends the same coverage requirement to a broad set of public and quasi-public coverage arrangements, including the State Employees Group Insurance Act, county and municipal self-insured plans, school employee coverage, health maintenance organizations, limited health service organizations, voluntary health services plans, and the Illinois Public Aid Code (Medicaid). It adds a new Insurance Code section governing stuttering treatment coverage, and it makes the mandate effective January 1, 2027. The bill further states that the State is not required to reimburse local governments for the cost of implementing the mandate under the State Mandates Act.
HB2628 would amend multiple Illinois statutes to create a new mandated health benefit for stuttering treatment, expanding coverage obligations across private insurance, state employee plans, local government self-insured plans, school district plans, HMOs, limited health service organizations, voluntary health services plans, and Medicaid. It also adds new statutory language in the Insurance Code defining the covered speech therapy services and limiting insurers’ ability to impose annual caps, diagnosis-based exclusions, or prior authorization/utilization review for the required coverage. The practical effect is to standardize access to speech therapy for stuttering across many types of coverage in Illinois.
No committee transcripts or recorded votes were provided, so there is no direct evidence of debate, support, or opposition in the available materials. Based on the bill text alone, the measure appears consumer- and patient-protective, aimed at expanding access to medically appropriate speech therapy. The absence of recorded opposition or amendments in the supplied context means the overall sentiment cannot be measured from legislative discussion history here.
The main policy tension in HB2628 is between expanded coverage for people who stutter and the cost/administrative impact on insurers, public employers, and Medicaid. The bill removes common utilization controls such as prior authorization and annual visit limits, which may concern payers and plan sponsors. Another possible point of contention is the breadth of the mandate, since it applies not only to private insurance but also to state, county, municipal, school, and public aid coverage, while also declaring the mandate an unfunded state requirement for local governments. No specific legislators, agencies, or stakeholder groups are identified in the provided record, so these concerns are inferred from the bill’s structure rather than from documented debate.